Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Feifei Song
Observed names:
F. Song,
Fei Fei Song,
Song, Feifei
Institutions:
Institute of Cancer Research,
Breast Cancer Now,
Institute of Cancer Research
Observed institutions:
Institute of Cancer Research,
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute,
Breast Cancer Now,
Cancer Research UK,
Institute of Cancer Research,
The Ohio State University
show all 6
ORCID:
0000-0001-8571-3111
Observed ORCID:
0000-0001-8571-3111
OpenAlex ID:
A5070334795
The shieldin complex mediates 53BP1-dependent DNA repair
2018
·
Sylvie M. Noordermeer
, Salomé Adam
, et al.
·
Nature
·
709
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance
2018
·
Stephen J. Pettitt
, Dragomir B. Krastev
, et al.
·
Nature Communications
·
500
PDF
Detection of Acute Radiation Sickness: A Feasibility Study in Non-Human Primates Circulating miRNAs for Triage in Radiological Events
2016
·
Naresh Menon
, Claude J. Rogers
, et al.
·
PLoS ONE
·
51
PDF
Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targets
2018
·
Dragomir B. Krastev
, Stephen J. Pettitt
, et al.
·
Nature Communications
·
33
PDF
SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
2022
·
Marta J. Llorca-Cardenosa
, Lauren I. Aronson
, et al.
·
Cancer Research
·
20
PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma
2025
·
James Stewart
, Dragomir B. Krastev
, et al.
·
Oncogene
·
19
PDF
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
2021
·
Ilirjana Bajrami
, Callum Walker
, et al.
·
Communications Biology
·
16
PDF
Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells
2017
·
Stephen J. Pettitt
, Dragomir B. Krastev
, et al.
·
Scientific Data
·
15
PDF
Replication Stress Is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors
2024
·
Asuka Kawai-Kawachi
, Madison M. Lenormand
, et al.
·
Cancer Research
·
12
PDF
MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells
2023
·
Anabel Zelceski
, Paola Francica
, et al.
·
Cell Reports
·
11
PDF
Cancer‐associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7
2023
·
Joseph S. Baxter
, Rachel Brough
, et al.
·
Molecular Oncology
·
6
PDF
Mutational and Functional Heterogeneity of Homology-Directed Repair Deficiency and Clinical Implications
2026
·
Salome Jingchen Zhao
, Gene Ching Chiek Koh
, et al.
·
SSRN Electronic Journal
·
3
LIG1 Loss in TP53 -mutant Triple-Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP–ATR Inhibitor Combinations
2026
·
Anh Minh Tran Huynh
, Jonathan T. Lei
, et al.
·
Molecular Cancer Therapeutics
·
1
Reversion mutations define minimal BRCA1/2 requirements for therapy resistance
2026
·
Lorena Magraner-Pardo
, William Kerrison
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PPP2R1A missense mutations as a novel biomarker of response to ATR inhibitors in ARID1A mutant ovarian clear cell carcinoma
2022
·
J. Stewart
, J. Baxter
, et al.
·
European Journal of Cancer
·
1
3P Identification of novel biomarkers of response to ATR inhibitors in ARID1A mutant ovarian clear cell carcinoma
2022
·
J.R. Stewart
, J. Baxter
, et al.
·
Annals of Oncology
·
1
Abstract 2743: Finding determinants of PARP inhibitor sensitivity using genome-wide and focused CRISPR screens
2016
·
Stephen Pettitt
, Dragomir B. Krastev
, et al.
·
Cancer Research
·
1
Figure 5 from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
2025
·
Marta J. Llorca-Cardenosa
, Lauren I. Aronson
, et al.
Figure 3 from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
2025
·
Marta J. Llorca-Cardenosa
, Lauren I. Aronson
, et al.
Figure 2 from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
2025
·
Marta J. Llorca-Cardenosa
, Lauren I. Aronson
, et al.
Figure 4 from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
2025
·
Marta J. Llorca-Cardenosa
, Lauren I. Aronson
, et al.
Figure 1 from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
2025
·
Marta J. Llorca-Cardenosa
, Lauren I. Aronson
, et al.
Figure 5 from Replication Stress Is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors
2025
·
Asuka Kawai-Kawachi
, Madison M. Lenormand
, et al.
Figure 2 from Replication Stress Is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors
2025
·
Asuka Kawai-Kawachi
, Madison M. Lenormand
, et al.
Figure 4 from Replication Stress Is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors
2025
·
Asuka Kawai-Kawachi
, Madison M. Lenormand
, et al.
Show more works
View as search
Works count:
39
Citation count:
1,400
H-index:
10
I10-index:
10
Year
Topic
Type